Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 139,229 182,993 316,353 594,697
Total Sell Value $12,316,080 $16,513,389 $28,948,007 $56,737,885
Total People Sold 5 5 6 7
Total Sell Transactions 11 15 24 53
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 2549
  Page 4 of 102  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Heron Elaine J Director   –       •      –    2023-05-12 4 OE $67.81 $576,385 D/D 8,500 94,068     -
   Meier Richard A Director   –       •      –    2023-05-12 4 D $93.93 $576,448 D/D (6,137) 111,357     -
   Meier Richard A Director   –       •      –    2023-05-12 4 OE $67.81 $576,385 D/D 8,500 117,494     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-05-12 4 D $93.93 $3,755,415 D/D (39,981) 432,732     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-05-12 4 OE $67.81 $3,153,165 D/D 46,500 472,713     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-05-11 4 AS $94.55 $2,840,226 D/D (30,000) 426,213     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-05-11 4 OE $67.81 $2,034,300 D/D 30,000 456,213     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-05-10 4 AS $94.65 $2,845,397 D/D (30,000) 426,213     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-05-10 4 OE $67.81 $2,034,300 D/D 30,000 456,213     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-05-09 4 AS $94.22 $2,847,973 D/D (30,000) 426,213     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-05-09 4 OE $67.81 $2,034,300 D/D 30,000 456,213     -
   Guyer Charles Greg EVP, Chief Technical Officer   •       –      –    2023-05-04 4 D $95.45 $410,626 D/D (4,302) 45,401     -
   Fuchs Henry J President, Worldwide R&D   •       –      –    2023-04-28 4 A $66.88 $21,200 D/D 317 176,504     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2023-04-28 4 A $66.88 $21,267 D/D 318 65,804     -
   Davis George Eric EVP, Chief Legal Officer   •       –      –    2023-04-28 4 A $66.88 $21,201 D/D 317 80,684     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-04-28 4 A $66.88 $21,201 D/D 317 426,213     -
   Guyer Charles Greg EVP, Chief Technical Officer   •       –      –    2023-04-28 4 A $66.88 $15,984 D/D 239 49,703     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-04-10 4 AS $99.56 $995,600 D/D (10,000) 425,896     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-04-10 4 OE $67.81 $678,100 D/D 10,000 435,896     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-04-06 4 AS $96.13 $961,300 D/D (10,000) 425,896     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-04-06 4 OE $67.81 $678,100 D/D 10,000 435,896     -
   Davis George Eric EVP, Chief Legal Officer   •       –      –    2023-03-16 4 D $93.41 $1,864,183 D/D (19,957) 80,367     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-03-16 4 D $93.41 $8,278,274 D/D (88,623) 425,896     -
   Fuchs Henry J President, Worldwide R&D   •       –      –    2023-03-16 4 D $93.41 $3,362,760 D/D (36,000) 188,187     -
   Mueller Brian EVP, Chief Financial Officer   •       –      –    2023-03-16 4 D $93.41 $371,118 D/D (3,973) 55,585     -
  2549 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 102
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us